PRVA - Privia Health Group, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 18.74

Open

$ 18.67

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 18.40 - $ 18.88

52 Week Range

$ 17.54 - $ 30.15

Volume

936,658

Average Volume

Market Cap

2.34B

Beta (5Y Monthly)

$ 0.77

PE Ratio (TTM)

$ 101.24

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-27-2024	12-31-2023	10-K
2	11-03-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-04-2023	03-31-2023	10-Q
5	03-01-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-25-2022	12-31-2021	10-K
10	11-08-2021	09-30-2021	10-Q
11	08-09-2021	06-30-2021	10-Q
12	05-28-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Stifel Maintains Buy on Privia Health Gr, ...
05/01/2024 13:22:07

Stifel analyst Craig Jones maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $28 to $24.

Where Privia Health Gr Stands With Analysts
04/22/2024 16:00:54

Citigroup Initiates Coverage On Privia Hea...
04/22/2024 13:01:01

Citigroup analyst Daniel Grosslight initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Buy rating and announces Pri...

Analyst Scoreboard: 8 Ratings For Privia H...
03/19/2024 15:01:10

Canaccord Genuity Maintains Buy on Privia ...
03/19/2024 10:46:04

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from...

JP Morgan Maintains Overweight Rating for ...
03/06/2024 17:00:35

JP Morgan Maintains Overweight on Privia H...
03/06/2024 16:16:01

JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and lowers the price target from $38 ...

Barclays Initiates Coverage On Privia Heal...
03/06/2024 11:57:13

Barclays analyst Andrew Mok initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight rating and announces Pr...

UBS Maintains Buy on Privia Health Gr, Low...
03/01/2024 16:52:19

UBS analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $31 to $29.

TD Cowen Maintains Outperform on Privia He...
03/01/2024 13:32:53

TD Cowen analyst Gary Taylor maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the price target from $30...

Forecasting The Future: 4 Analyst Projecti...
02/29/2024 17:01:03

Truist Securities Maintains Buy on Privia ...
02/29/2024 14:23:38

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target fr...

Evercore ISI Group Maintains Outperform on...
02/28/2024 17:23:47

Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the pric...

Privia Health Group Expects FY24 Revenue o...
02/27/2024 11:17:32

2024 Financial and Business Outlook g h i Privia Health’s key actions and areas of focus in 2024 include: Increasing densit...

Privia Health Gr Q4 2023 Adj EPS $0.15 Bea...
02/27/2024 11:05:21

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.0...

Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

Privia Health Gr's Earnings: A Preview
02/26/2024 15:02:24

B of A Securities Downgrades Privia Health...
02/22/2024 17:00:24

B of A Securities Downgrades Privia Health...
02/22/2024 14:32:51

B of A Securities analyst Adam Ron downgrades Privia Health Gr (NASDAQ:PRVA) from Buy to Neutral and lowers the price target...

why-panbela-therapeutics-shares-are-trading-lower-by-65-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Panbela Therapeutics Shares Are Tradin...
01/29/2024 19:09:05

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of...